The United States Food and Drug Administration (FDA) has approved a treatment for sickle cell disease. The therapy, called Casgevy, from Vertex Pharmaceuticals and CRISPR Therapeutics, is the first medicine to be approved in the United States that uses the gene-editing tool CRISPR, which won its inventors the Nobel...
U.S. agency approves gene-editing treatments for sickle cell disease which costs millions of dollars per patient
